What is it?
What Saffron is
3Saffron is the dried stigma of Crocus sativus. This profile is for comparing supplement labels, research context, and safety limits; it is not a medical or nootropic claim.
Names, aliases and forms
Mechanisms of action
Research context, not a mechanism claim
1Human studies have examined Saffron preparations in depressive-symptom contexts. Those findings do not establish how every Saffron product works, nor a cognition benefit for generally healthy adults.
Potential effects and evidence map
Human trials and meta-analyses have examined Saffron preparations for depressive symptoms, but formulations, populations, and study duration vary. The cited research does not establish a clinically validated mood or cognitive-enhancement benefit.
Human studies have evaluated Saffron preparations for depressive symptoms; this does not establish clinical use, general-wellbeing, or cognitive-enhancement benefit.
Typical dosages and timing
One small randomized trial used 30 mg/day for six weeks. That is a study detail—not a universal dose or a recommendation—because Saffron products and clinical contexts vary.
Safety, side effects and risk profile
The cited human safety review reports gastrointestinal effects most often; they were usually minor and self-limiting.
Ask a pharmacist or clinician before use with prescription medicines, particularly narrow-therapeutic-index medicines; potential enzyme effects have uncertain clinical relevance.
Avoid self-directed supplemental use during pregnancy and seek obstetric advice; pregnancy evidence is limited and higher consumption has risk concerns.
Products, study populations, and durations vary across the human evidence base.
A human safety review found gastrointestinal effects were reported most often and were usually minor and self-limiting. Higher-dose or prolonged medicinal use needs additional clinical caution.
Interactions and cautions
Ask a pharmacist or clinician before combining Saffron with prescription medicines, particularly narrow-therapeutic-index medicines: potential enzyme effects have uncertain clinical relevance.
Legal and regulatory status
United States, as of August 2026: a botanical may be sold as a dietary supplement when it meets applicable requirements. FDA does not approve dietary supplements for safety and effectiveness before marketing; that is not an FDA endorsement and rules differ elsewhere.
Practical buying and quality notes
- Compare Crocus sativus identity, stigma versus extract form, extract ratio or standardization, serving size, and other ingredients. A study preparation may not match a retail product.3
FAQ
Is Saffron an established nootropic?
1No. The cited human research concerns depressive symptoms, not cognitive enhancement in generally healthy adults. Do not use this comparison page in place of professional support for a mood condition.
References
- Dai L, Chen L, Wang W. Safety and efficacy of saffron (Crocus sativus L.) for mild to moderate depression: a systematic review and meta-analysis. J Nerv Ment Dis. 2020;208(4):269-276. PMID: 32221179.
- Hasheminasab FS, Hajimonfarednejad M, Najibi SM, Hashempur MH. Adverse Events of Saffron (Crocus sativus L.): Systematic Review of Current Evidence. Health Sci Rep. 2026. PMID: 42057871.
- Akhondzadeh S, et al. Crocus sativus L. in mild to moderate depression: a double-blind, randomized, placebo-controlled trial. Phytother Res. 2005. PMID: 15852492.
- Bathaei P, et al. Effects of Crocus sativus and its active constituents on cytochrome P450: a review. 2025. PMID: 40167627.
- Alshdefat A, et al. Saffron and pregnancy: cultural practices, beliefs, and safety evidence: an integrative review. 2026. PMID: 42186868.
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements. Accessed August 24, 2026.